红细胞生理压力导致质量较差的输血:一项针对状细胞疾病成年人的随机试验
Matthew S Karafin1, Ross M Fasano2, Anton Ilich3
1Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.
Blood. Red cells & iron
|November 28, 2025
概括
红细胞单位具有较高的危险标志物,而不仅仅是储存年龄,恶化状细胞疾病的结果. 这包括降低血红蛋白,更多的疼痛危机和增加的疾病,影响患者的安全.
科学领域:
- 血液学 血液学 血液学
- 输血医学 输血医学
- 临床研究 临床研究
背景情况:
- 状细胞病 (SCD) 患者通常会收到接近到期的红血细胞 (RBC) 单位,使他们暴露于储存损伤效应中.
- 红细胞储存年龄和危险标志物对慢性输血SCD成年人的影响需要进一步的临床评估.
研究的目的:
- 评估红细胞储存年龄和应急标记在慢性输血成人SCD患者的临床影响.
- 评估红细胞中的脂胺 (PS) 和脂乙胺 (PE) 暴露是否会影响患者的治疗结果.
主要方法:
- 一项随机前性临床试验,涉及26名慢性输血成人SCD患者.
- 参与者在3次输血事件中接受了≥30天或≤10天的储存红细胞单位.
- 评估了PS和PE表面暴露的红细胞单位;分析了临床变量.
主要成果:
- 在红细胞上更高的PS和PE暴露与降低的血红蛋白增加 (0.59vs1.04g/dL),增加的疼痛危机 (IRR7.44) 和更高的疾病概率 (OR1.94) 相相关.
- 输血后血清铁预测疾病症状 (AUC 0.76) 并与较低的HbA%增加相关 (r=-0.36).
- 这些效应无论红细胞存储年龄如何都被观察到.
结论:
- 输血红细胞的生理状态,由PS/PE暴露等危险标志物表明,显著影响SCD患者的结果.
- 避免低质量的红细胞单位可能会提高高风险SCD人群的患者安全.
- 进一步的研究应侧重于识别和减轻与输血红细胞质量相关的风险.
更多相关视频
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
20.2K
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
10.3K
相关概念视频
Factors Affecting Erythropoiesis
5.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.4K
Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Erythropoiesis
5.7K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.7K
Oxygen Transport in the Blood
5.8K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
5.8K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Overview of Hematopoiesis
8.2K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.2K
